CHECKPOINT CAPITAL L.P.

PrivateCIK: 1977548
Location

SAN FRANCISCO, CA

πŸ“‹ What this filing means

CHECKPOINT CAPITAL L.P. filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $201.57M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

16
Positions
$201.57M
Total AUM (reported)
8.54M
Total Shares

Allocation by class

TOTAL AUM$201.57M16 positions
COM$107.34M53.3%
SPONSORED ADR$50.14M24.9%
COM NEW$29.67M14.7%
COM SHS$14.43M7.2%

Portfolio Concentration

Top 355.6%4–1039.8%11–254.6%TOP 1095.4%0%100%
Top 3$112.09M55.6%
4–10$80.14M39.8%
11–25$9.34M4.6%

Top 3 weight

55.6%

Top 10 weight

95.4%

Voting Authority Distribution

Total shares with voting rights: 8.54M

Sole

Full voting authority

8.54M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole16
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings16
Rows:

ARGENX SE

SOLE
SPONSORED ADR
Shares92.50K
TypeSH
Market value$50.14M
24.88%
Sole
92.50K
Shared
0.00
None
0.00

RHYTHM PHARMACEUTICALS INC

SOLE
COM
Shares663.38K
TypeSH
Market value$34.75M
17.24%
Sole
663.38K
Shared
0.00
None
0.00

PHATHOM PHARMACEUTICALS INC

SOLE
COM
Shares1.50M
TypeSH
Market value$27.20M
13.49%
Sole
1.50M
Shared
0.00
None
0.00

CYTOKINETICS INC

SOLE
COM NEW
Shares466.81K
TypeSH
Market value$24.65M
12.23%
Sole
466.81K
Shared
0.00
None
0.00

AXSOME THERAPEUTICS INC

SOLE
COM
Shares209.63K
TypeSH
Market value$18.84M
9.35%
Sole
209.63K
Shared
0.00
None
0.00

AVADEL PHARMACEUTICALS PLC

SOLE
COM SHS
Shares1.10M
TypeSH
Market value$14.43M
7.16%
Sole
1.10M
Shared
0.00
None
0.00

PROTAGONIST THERAPEUTICS INC

SOLE
COM
Shares240K
TypeSH
Market value$10.80M
5.36%
Sole
240K
Shared
0.00
None
0.00

PLIANT THERAPEUTICS INC

SOLE
COM
Shares380K
TypeSH
Market value$4.26M
2.11%
Sole
380K
Shared
0.00
None
0.00

TSCAN THERAPEUTICS INC

SOLE
COM
Shares825.34K
TypeSH
Market value$4.11M
2.04%
Sole
825.34K
Shared
0.00
None
0.00

ATYR PHARMA INC

SOLE
COM NEW
Shares1.74M
TypeSH
Market value$3.06M
1.52%
Sole
1.74M
Shared
0.00
None
0.00

SOLENO THERAPEUTICS INC

SOLE
COM
Shares57.98K
TypeSH
Market value$2.93M
1.45%
Sole
57.98K
Shared
0.00
None
0.00

CIDARA THERAPEUTICS INC

SOLE
COM NEW
Shares182.43K
TypeSH
Market value$1.96M
0.97%
Sole
182.43K
Shared
0.00
None
0.00

STOKE THERAPEUTICS INC

SOLE
COM
Shares157.51K
TypeSH
Market value$1.94M
0.96%
Sole
157.51K
Shared
0.00
None
0.00

DISC MEDICINE INC

SOLE
COM
Shares25.54K
TypeSH
Market value$1.26M
0.62%
Sole
25.54K
Shared
0.00
None
0.00

TREVI THERAPEUTICS INC

SOLE
COM
Shares250K
TypeSH
Market value$835.0K
0.41%
Sole
250K
Shared
0.00
None
0.00

ALLAKOS INC

SOLE
COM
Shares649.96K
TypeSH
Market value$424.6K
0.21%
Sole
649.96K
Shared
0.00
None
0.00
CHECKPOINT CAPITAL L.P. 13F Holdings β€” 16 Positions | Finecho